<?xml version="1.0" encoding="UTF-8"?>
			<!DOCTYPE ijpp.edwiserinternational.com [
<!ELEMENT channel (title,link,description,language,managingEditor,webMaster,copyright,image,item,item,item,item,item)>
<!ELEMENT title (#PCDATA)>
<!ELEMENT link (#PCDATA)>
<!ELEMENT language (#PCDATA)>
<!ELEMENT managingEditor (#PCDATA)>
<!ELEMENT webMaster (#PCDATA)>
<!ELEMENT copyright (#PCDATA)>

<!ELEMENT image (title,link,url,width,height)>
<!ELEMENT url (#PCDATA)>
<!ELEMENT width (#PCDATA)>
<!ELEMENT height (#PCDATA)>

<!ELEMENT item (title,pubDate,link,author,comments,category,description)>
<!ELEMENT pubDate (#PCDATA)>
<!ELEMENT author (#PCDATA)>
<!ELEMENT comments (#PCDATA)>
<!ELEMENT category (#PCDATA)>
<!ELEMENT description (#PCDATA)>

]>
		<channel>
<title>Journal-of-Pharmaceutical-Research-Science-Technology-ISSUE VOLUME Volume 2 ISSUE Issue 1</title>
<link>http://ijpp.edwiserinternational.com/rss-feed.php</link>
<description>
Journal-of-Pharmaceutical-Research-Science-Technology: VOLUME Volume 2 ISSUE Issue 1, Jan-Mar 2018
</description>
<language>en-us</language>
<managingEditor>editor@edwiserinternational.com</managingEditor>
<webMaster>editor@edwiserinternational.com</webMaster>
<copyright>editor@edwiserinternational.com</copyright>
<image>
<title>Journal-of-Pharmaceutical-Research-Science-Technology-ISSUE VOLUME Volume 2 ISSUE Issue 1</title>
<link>http://ijpp.edwiserinternational.com/rss-feed.php</link>
<url>http://ijpp.edwiserinternational.com/img/logo1.png</url>
<width>360</width>
<height>109</height>
</image><item>
		<title>An-Overview-on-Haemovigilance-Part-of-Pharmacovigilance</title>
		<pubDate>22-Dec-2018</pubDate>
<link>http://ijpp.edwiserinternational.com/admin/uploads/OMSDHr.pdf</link>
		<author>Kapoor-DU-Dadarwal-D-Vyas-RB-et-al-</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science</category>
		<description>{<![CDATA[Haemovigilance plays an indispensable role in confirming patient safety with regard to blood transfusions. Haemovigilance is a structured scheme of observing, identifying, reporting, investigating and analysing adverse events and reactions pertinent to transfusion and manufacturing blood products. This system is also a rudimentary part of quality control in a blood system, bringing about counteractive and preventive measures, and for the perpetual advancement of the quality and safety of blood products and the transfusion process. The data generated through the haemovigilance system helps in framing important changes in the whole blood transfusion process which are useful for better patient safety. This article momentarily reveals the history of haemovigilance, necessity of haemovigilance and also explain about the Haemovigilance program of India]]>}</description>
		</item><item>
		<title>Hybrid-Nanocarbon-Materials-for-Magnetic-Resonance-and-Fluorescent-Imaging-A-Mini-Review</title>
		<pubDate>22-Dec-2018</pubDate>
<link>http://ijpp.edwiserinternational.com/admin/uploads/gvRYmk.pdf</link>
		<author>Rui-Lin-Liu-and-Jia-Xuan-Hou-</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science</category>
		<description>{<![CDATA[Carbon nanomaterials have gained significant momentum as promising candidate materials for biomedical applications due to their unique structure and properties. Carbon-based nanohybrids can be used as magnetic and fluorescent imaging contrast agent agents when it was functionalized by magnetic and fluorescent components. This mini-review summarizes the ultramodern applications and developments of hybrid carbon materials and addresses the future perspectives of carbon-based magnetic and fluorescent nanohybrids in the biomedical field. ]]>}</description>
		</item><item>
		<title>Maul-Jubn-A-Potent-and-Novel-Unani-Formulation-</title>
		<pubDate>22-Dec-2018</pubDate>
<link>http://ijpp.edwiserinternational.com/admin/uploads/xHvbCn.pdf</link>
		<author>Ahmad-P-Monis-M-Baig-Z-et-al-</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science</category>
		<description>{<![CDATA[Maul-Jubn (Whey) a by-product of the dairy industry is used since thousands of years as nutraceuticals in the traditional system of medicine. For several years it was thought to be insignificant and was either used as an animal feed or it was disposed off as waste. But Over the last years several studies were carried out concerning the importance of nutritional value of whey and the properties of its ingredients. It is now accepted that its main content, whey proteins, have antimicrobial, antiviral and anti-oxidant properties, can offer a kind of protection against cancer and heart diseases and assist at the enhancement of immune defence. In Unani medicine the importance of Maul-Jubn in the prevention and treatment was well known to Unani physicians since ancient time, and abundant literature regarding the use and methods of preparation have been discussed. The present study attempted to discuss the importance of Maul-Jubn in the perspective of Unani medicine with addition of some recent scientific reports.   ]]>}</description>
		</item><item>
		<title>Use-of-Continuous-Infusion-Epoprostenol-in-a-Patient-with-Secondary-Raynauds-Phenomenon-</title>
		<pubDate>22-Dec-2018</pubDate>
<link>http://ijpp.edwiserinternational.com/admin/uploads/R9THhZ.pdf</link>
		<author>Lemieux-SM-Lopez-F-Eng-CC-et-al-</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science</category>
		<description>{<![CDATA[Purpose: To describe a unique prostacyclin dosing regimen utilized to treat a case of secondary Raynauds phenomenon and summarize the existing literature on parenteral prostacyclin use for Raynauds phenomenon in adult patients.   Summary: A 54-year-old female was admitted for initiation of continuous intravenous infusion epoprostenol to treat secondary Raynauds phenomenon which failed to respond to nifedipine and sildenafil.  The infusion was titrated to a target dose of 9 ng/kg/min for 5 days.  Upon completion of treatment, improvements in the patients pain, range of motion, and digital perfusion were observed.  Sustained improvements were noted seven weeks later.  Parenteral prostacyclins may therefore be considered for Raynauds phenomenon which fails to respond to conventional therapies.  Epoprostenol has previously been used to treat Raynauds phenomenon mainly in the form of intermittent, intravenous infusions.  There are logistical concerns associated with the use of a continuous infusion prostacyclin which should be addressed before this therapy is chosen. Conclusion: This case highlights a successful outcome in a patient with secondary Raynauds phenomenon treated with a 5-day continuous infusion of epoprostenol.  It is reasonable to consider this treatment regimen in patients with secondary Raynauds phenomenon in whom other treatments have failed.]]>}</description>
		</item><item>
		<title>Metabolite-Profiling-and-Principle-Component-Analysis-of-a-Mangrove-Plant-Aegiceras-Corniculatum-L-Blanco-</title>
		<pubDate>22-Dec-2018</pubDate>
<link>http://ijpp.edwiserinternational.com/admin/uploads/sMKq2O.pdf</link>
		<author>Bidve-SC-Kadam-VB-Malpathak-NP</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science</category>
		<description>{<![CDATA[Metabolite profiling is the multi-parallel relative quantification of a mixture of compounds or compound classes using chromatography and universal detection technologies (GC-MS, LCMS) for biological samples. Metabolic profiling could provide the link between traditional herbal medicines and molecular pharmacology. Aegiceras corniculatum is one of the important species of black river mangrove plant. Present studies explaining the strategies of metabolite profiling of polar as well as non-polar compounds from leaves and bark extracts of plant Aeiceras corniculatum by using GCMS. The range of solvent from non-polar to polar viz. petroleum ether, chloroform, ethyl acetate, methanol and water separately used for extraction. The GC-MS profile revealed the presence of phenolics, carbohydrates, steroids, alkaloids, hydrocarbons, fatty acids and esters, amines etc. In parallel with GC-MS statistical analytical tools such as principal component analysis used to yield significant and precise results. In present study the biologically active compounds-Plectoxanxthin, Ndeacetyl Colchicine, Cyclopentaneundecanoic acid, Thiirane, Gamolenic acid, 8,11,14-Eicosatrienoic acid, Lupol, Rhodopine were reported from different extracts of plant. ]]>}</description>
		</item></channel>